Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
20-Dec-2022
Letter to Shareholders End of Year Summary and 2023 Plans
1-Dec-2022
Final Director's Interest Notice - Dr. John Lambert
29-Nov-2022
ACCENT Trial Recruitment Progress
18-Nov-2022
Appendix 4D and Financial Report Half Year ended 30 Sep 22
7-Nov-2022
Amplia Appoints Dr Christopher Burns CEO & Managing Director
28-Oct-2022
Quarterly Activities and Cashflow Reports - Sep 2022 Qtr
10-Oct-2022
Notification regarding unquoted securities - ATX
3-Oct-2022
AMP886 Activity in Acute Myeloid Leukemia
14-Sep-2022
AACR Conference Presentation
12-Sep-2022
CEO Resignation
1
2
3
4
5
6
Next
